HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

V W Pike Selected Research

Adenosine Monophosphate (AMP)

1/2017cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


V W Pike Research Topics

Disease

2Heart Failure
08/2003 - 03/2000
1Major Depressive Disorder (Major Depressive Disorders)
01/2017
1Alcoholism (Alcohol Abuse)
08/2013
1Marijuana Abuse (Cannabis Abuse)
06/2012
1Body Weight (Weight, Body)
01/2002
1Movement Disorders (Movement Disorder)
06/2000
1Cardiomyopathies (Cardiomyopathy)
03/2000
1Myocardial Ischemia (Ischemic Heart Diseases)
03/2000
1Hypertension (High Blood Pressure)
03/2000

Drug/Important Bio-Agent (IBA)

2CannabinoidsIBA
08/2013 - 06/2012
2Adrenergic Receptors (Adrenergic Receptor)IBA
08/2003 - 03/2000
1Adenosine Monophosphate (AMP)IBA
01/2017
1Antidepressive Agents (Antidepressants)IBA
01/2017
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
08/2013
1iodo- insulinIBA
01/2002
1Olanzapine (Zyprexa)FDA Link
06/2000
1Antipsychotic Agents (Antipsychotics)IBA
06/2000

Therapy/Procedure

1Intravenous Injections
01/2002